46.56 -0.03 (-0.06%)
After hours: 7:59PM EDT
|Bid||46.56 x 1000|
|Ask||46.58 x 1200|
|Day's Range||45.99 - 46.90|
|52 Week Range||42.40 - 66.04|
|Beta (3Y Monthly)||0.35|
|PE Ratio (TTM)||13.91|
|Forward Dividend & Yield||3.20 (6.92%)|
|1y Target Est||N/A|
Altria Group, Inc. today announced that its Board of Directors voted to increase Altria’s regular quarterly dividend for the 54th time in the past 50 years.
Altria Group, Inc. today announces its 2019 second-quarter and first-half business results and reaffirms its guidance for 2019 full-year adjusted diluted earnings per share .
Altria Group, Inc. will host a live audio webcast on Tuesday, July 30, 2019, at 9:00 a.m. Eastern Time to discuss its 2019 second-quarter business results. Altria will issue a press release containing its business results at approximately 7:00 a.m.
Altria Group, Inc. (Altria) (MO) today announces that it has entered into definitive agreements with the shareholders of Burger Söhne Holding AG (the “Burger Group”), based in Switzerland, to acquire 80% ownership of certain companies of the Burger Group that will commercialize on! products worldwide. “We’re excited to add on! to our companies’ terrific non-combustible portfolio,” said Howard Willard, Altria’s Chairman and Chief Executive Officer. “Through our companies and investments, we have access to the leading products and brands in the moist smokeless tobacco, e-vapor and heated tobacco categories.
RICHMOND, Va.-- -- Altria discusses evolved business platform and recent strategic investments. Altria announces Annual Meeting voting results. Altria reaffirms full-year 2019 earnings guidance. Altria declares regular quarterly dividend of $0.80 per share. Altria Group, Inc. held its 2019 Annual Meeting of Shareholders today. Howard Willard, Altria’s Chairman and Chief Executive Officer, summarized ...
Altria Group, Inc. will host a live audio webcast of its 2019 Annual Meeting of Shareholders on Thursday, May 16, 2019 at 9:00 a.m. Eastern Time.
Altria Group, Inc. announces today that the Food and Drug Administration authorized sale of the IQOS heated tobacco system in the U.S. market. FDA authorization follows review of the Premarket Tobacco Product Applications submitted by Philip Morris International Inc.
Altria Group, Inc. today announces its 2019 first-quarter business results and reaffirms its guidance for 2019 full-year adjusted diluted earnings per share .
Altria Group, Inc. -- In response to the announcement today by Senate Majority Leader McConnell for plans to introduce legislation to raise the age of pur
NEW YORK, April 18, 2019 /CNW/ -- The tremendous growth of the cannabis market is causing the marketspace to become an emerging global industry. Under international regulations, cannabis is one of the most heavily enforced drugs, primarily due to the psychoactive effects of marijuana. The marijuana plant is comprised primarily of THC, which causes the psychoactive effects.
HENDERSON, NV / ACCESSWIRE / April 12, 2019 / The Cowen Group has projected that the cannabis industry will see $75 billion in global annual sales by 2030, up from a previous forecast of $50 billion by ...
Altria Group, Inc. (Altria) (MO) will host a live audio webcast on Thursday, April 25, 2019, at 9:00 a.m. Eastern Time to discuss its 2019 first-quarter business results. Altria will issue a press release containing its business results at approximately 7:00 a.m. Eastern Time the same day. The webcast can be accessed at altria.com or through the Altria Investor App.
In October 2018, Canada became the second country to ever legalize cannabis entirely, joining Uruguay on that short list. Meanwhile, globally, a string of countries such as Australia, Germany, and South Korea began accelerating their medical cannabis programs.
Altria Group, Inc. (Altria) (MO) today announces it has received a request for additional information (Second Request) from the U.S. Federal Trade Commission (FTC) relating to its investment in JUUL Labs, Inc. (JUUL) that closed in December 2018. Altria currently holds an approximate 35% non-voting, economic interest in JUUL. Altria is now seeking to convert its JUUL interest to voting securities pursuant to the terms of its investment.
Marijuana and hemp are also two derivatives of the cannabis family. Now, researchers have realized that marijuana can be used for medical applications to treat conditions such as cancer and chronic pain. Additionally, while the use of marijuana and hemp is more common now for medical applications, there is still a large recreational market, particularly in the U.S. and Canada.
PALM BEACH, Florida, March 13, 2019 /CNW/ -- The passage of the U.S. Farm bill, which restored industrial hemp to nationwide legal production for the first time since World War II, has been generating a financial windfall for North American cannabis companies. A recent post from industry watchers on the net said: "More broadly, the passage of the Farm Bill represents a sweeping change in the balance of power in global hemp markets. The United States has historically been an importer of hemp products from Canada, Europe, and China.
Cronos Group Inc. (CRON.TO) (CRON.TO) (“Cronos Group” or the “Company”) today announced that the C$2.4 billion equity investment in the Company by Altria Group, Inc. (MO) (“Altria”) has closed. As previously announced, Altria’s investment represents an approximate 45% ownership interest in Cronos Group.
Altria’s investment represents an approximate 45% economic and voting interest in Cronos Group with a warrant to acquire additional ownership at a price of CAD $19.00 per share, exercisable over the next four years. If exercised in full today, the warrant would increase Altria’s ownership in Cronos Group to approximately 55%. Under the terms of the transaction, Altria nominated four directors who were recently elected to serve on Cronos Group’s seven member board: Kevin C. Crosthwaite, Jr., Murray R. Garnick, Bruce A. Gates and Bronwen Evans.
NEW YORK, March 04, 2019 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
Altria Group, Inc. today announced that its Board of Directors declared a regular quarterly dividend of $0.80 per common share, payable on April 30, 2019, to shareholders of record as of March 25, 2019.
Cronos Group Inc. (CRON) (CRON.TO) (“Cronos Group” or the “Company”) announced that at a Special Meeting held today, the Company’s shareholders overwhelmingly approved the previously announced strategic investment agreement with Altria Group, Inc. (MO) (“Altria”). Pursuant to the agreement, at closing, Altria will make an approximately C$2.4 billion equity investment in Cronos Group (the “Transaction”) on a private placement basis in exchange for common shares (the “Shares”) in the capital of the Company.
Altria Group, Inc. is participating in the Consumer Analyst Group of New York Conference in Boca Raton, Florida today. Howard Willard, Altria’s Chairman and Chief Executive Officer, and other members of Altria’s senior management team will highlight Altria’s recent strategic investments, the current regulatory environment and Altria’s plans for its wholly-owned tobacco businesses and diverse business ...
Altria Group, Inc. will host a webcast of its business presentation at the annual Consumer Analyst Group of New York conference in Boca Raton, Florida, on Wednesday, February 20, 2019, at approximately 9:00 a.m.
LOS ANGELES, Feb. 05, 2019 -- Applied BioSciences Corp. (OTCQB: APPB), a diversified cannabinoid therapeutics company focused on the medical, bioceutical and pet health.